One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans who ...

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine.

Heart disease has been the leading cause of death in the U.S. for 100 years, according to the American Heart Association’s 2024 Heart Disease and Stroke Statistics report. For decades, beta-blockers ...

People prescribed a particular medication are reminded to contact their GP if they develop certain side effects that "bother" them. These are "commonly reported" and could require treatment if they ...

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with ...

The 3 common mainstays of angina therapy are beta-blockers, calcium channel blockers, and nitrates. These medicines treat the chest pain and provide other benefits as well. Isosorbide is a nitrate, ...

ATLANTA — Beta blockers are a mainstay in cardiovascular treatment, frequently given to patients after heart attacks. But a new large trial turns that convention on its head, suggesting that the drugs ...

Long-term oral Beta-blocker therapy, including bisoprolol, metoprolol, and carvedilol, reduces the composite endpoint of all-cause death, new myocardial infarction, or heart failure by 25% ...

Credit: Getty Images. A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. The role of beta-blockers after acute ...

MADRID -- Beta-blockers may be relegated to a smaller role for secondary prevention after myocardial infarction (MI) in contemporary practice, based on the arrival of three new trials from Europe.